Detail akcie Stryker online

Business Summary: Stryker Corporation is a medical technology company. The Company offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The Company also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, Stryker Corp revenues increased 11% to $25.12B. Net income increased 8% to $3.25B. Revenues reflect MedSurg and Neurotechnology segment increase of 16% to $15.65B, United States segment increase of 12% to $19.01B, Europe & Middle East & Africa (EMEA) (Region) segment increase of 10% to $3.18B, Asia Pacific (Region) segment increase of 7% to $2.16B. Dividend per share increased from $3.24 to $3.40.